
Key Presentations in Hodgkin and Non-Hodgkin Lymphomas from the 2022 ASH Annual Meeting with Dr Matthew Lunning
Oncology Today with Dr Neil Love
00:00
Mantle Cell Lymphoma
I just don't know the path forward here at least with this cell mod I think the cell mod class is interesting but again I guess I kind of said it I'm not sure that is better than a little little bit plus a monoclonal antibody. Yeah I'm still waiting for one of those to get approved in myeloma we've been hearing about it for years. yeah so we're going to jump back to the middle of the road which I saw is you know mantle cell lymphoma always has one leg straddling both sides of the aggressive and indolent fence. It was the talk of the town at ash it was in the big easy this year I think everybody
Transcript
Play full episode